For example, upregulating Scn1a expression using anti-sense RNA approaches has been shown to be an effective means of reducing seizures in a model of Dravet syndrome [36]. This evidence concerns the gene SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.